Ostia Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Haveli, Maharashtra, India, established in 2025.
2025 Haveli, Maharashtra, India Active
Last Updated:
Access Report
About Ostia Pharmaceuticals Private Limited

Ostia Pharmaceuticals Private Limited, a active private limited company, was established on 01 March 2025 in Haveli, Maharashtra, India. Engaging in manufacturing within the paper sector, it holds CIN: U21001PN2025PTC238842. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Akshay Vilas Dhumal (Director), Amol Ramchandra Mazire (Director), Sharad Jadhav (Director). It is based at Flat No 8 Wing C S No 8, Chandrama Residency, Haveli, Maharashtra, 411046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21001PN2025PTC238842

  • Registration Number

    238842

  • Incorporation Date

    01 March 2025

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Months 26 Days
Company report

Ostia Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ostia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ostia Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Akshay Vilas Dhumal Director 01 Mar 2025 Current
Amol Ramchandra Mazire Director 01 Mar 2025 Current
Sharad Jadhav Director 01 Mar 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ostia Pharmaceuticals.
Ostia Pharmaceuticals revenue growth over time
Ostia Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ostia Pharmaceuticals?

Unlock access to Ostia Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ostia Pharmaceuticals?

Unlock and access historical data on people associated with Ostia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ostia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ostia Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ostia Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Akshay Vilas Dhumal was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 26 days . was recorded as a recent event.

  • Director Appointment

    The activity Amol Ramchandra Mazire was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 26 days . was completed.

  • Director Appointment

    Sharad Jadhav was appointed as a Director was appointed as a Director on 01 Mar 2025 & has been associated with this company since 11 months 26 days . was recorded as a recent event.

  • Company Incorporation

    The activity Ostia Pharmaceuticals Private Limited was registered on 01 Mar 2025 with Roc Pune & aged 11 months 26 days as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ostia Pharmaceuticals Private Limited?

The CIN of Ostia Pharmaceuticals Private Limited is U21001PN2025PTC238842.

Where is Ostia Pharmaceuticals Private Limited headquartered?

Ostia Pharmaceuticals Private Limited is headquartered at Flat No 8 Wing C S No 8, Chandrama Residency, Haveli, Maharashtra, 411046.

When was Ostia Pharmaceuticals Private Limited incorporated?

Ostia Pharmaceuticals Private Limited was incorporated on 01 March 2025.

Who are the current directors of Ostia Pharmaceuticals Private Limited?

The current directors of Ostia Pharmaceuticals Private Limited are

What is the primary industry of Ostia Pharmaceuticals Private Limited?

The primary industry of Ostia Pharmaceuticals Private Limited is Paper.

Is Ostia Pharmaceuticals Private Limited a listed company?

Ostia Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Ostia Pharmaceuticals Private Limited?

The authorized capital of Ostia Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available